International Clinical Trial: Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07529028) titled 'Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy' on April 7.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.

Condition: Atrial Septal Defect

Intervention: Device: Absnow II Absorbable Atrial Septal Defect Occluder System

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 2026

Target Sample Size: 236

To know more, visit https://c...